Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ad-inserter domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/n9v8e4u0p3/domains/zeetechnical.com/public_html/wp-includes/functions.php on line 6121

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the digital-newspaper domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/n9v8e4u0p3/domains/zeetechnical.com/public_html/wp-includes/functions.php on line 6121
Dexcom Inc Archives » ZEE TECHNICAL Dexcom Inc Archives » ZEE TECHNICAL
106243803 1573684757414img 9321r

Dexcom shares fall on slow revenue growth

[ad_1] Dexcom CEO Kevin Sayer. Scott Mlyn | CNBC Shares of Dexcom fell 9% in extended trading on Thursday after the company released third-quarter results that beat analysts’ expectations but showed a decline in U.S. revenue year over year. Here’s what the company reported compared with what Wall Street was expecting, based on a survey…

Read More
107266071 1688386896223 gettyimages 1251770563 OBESITYINSURANCE

Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024

[ad_1] For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she was “done with the shaming.” Investors in drug manufacturers Novo Nordisk and Eli Lilly might use the same term for the returns they’ve realized over the past year. U.S.-listed shares of Novo Nordisk, the…

Read More